Clinical Trials Browser

Phase 2 × Lung Neoplasms × neratinib × Clear all

NCT01827267 2018-07-03

Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer

Phase 2 Completed

62 enrolled 12 charts

Lung Neoplasms

NCT00266877 2018-04-13

Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

172 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms